Biohaven Reports Second Quarter 2020 Financial Results And Recent Business Developments
- Monday, August 10, 2020, 7:04
- Finance
- Add a comment
NEW HAVEN, Conn., Aug. 10, 2020 /PRNewswire/ — Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN), a commercial-stage biopharmaceutical company with a portfolio of innovative, late-stage product candidates targeting neurological and neuropsychiatric diseases, today reported…
About the Author
adminasapcorp has written 41555 stories on this site.